Press Releases
-
Celerion Receives a 2023 CRO Leadership Award in All Categories for the Eighth Year Running
May 17, 2023
-
AMP Offers Evidence-Based Recommendations for Next-Generation Sequencing Germline Variant Confirmation
New AMP report offers recommendations for NGS germline variant confirmation
May 17, 2023
-
CD Genomics Harnesses Single-cell DNA Methylation Sequencing Service to Drive Scientific Breakthroughs
May 18, 2023
-
CD Genomics Expands Services with Pre-made Library Sequencing for High-Throughput Analysis
May 15, 2023
-
CD Genomics Unveils Cutting-Edge Long-Read Metagenomic Sequencing Service
May 18, 2023
-
CTMC AWARDED $9.1M THROUGH CPRIT GRANT FOR THE ADVANCEMENT OF CELL THERAPY
CTMC, a joint venture between Resilience + MD Anderson Cancer Center, announces that it has been awarded $9.1M in the newly created Cancer Prevention & Research Institute of Texas (CPRIT) Texas New Technologies Company grant. The grant will focus on retroviral vector (RVV) manufacturing, an enhanced tumor-infiltrating lymphocytes (TIL) platform, and a differentiated process development approach to CAR-T manufacturing.
May 17, 2023
-
Vitality of Hyaluronic acid, L-vitamin C, Coenzyme Q10, Alpha hydroxy acid, and Hexapeptide
May 4, 2023
-
Stable-Isotope Labeling: A Valuable Tool for Researchers Across Various Fields
Stable-isotope labeling is a powerful tool widely used in most MS-based assays to investigate the topology and operation of metabolic networks. In such cases, accurate quantification is often required. As a supplier of nearly all kinds of chemicals and materials, Alfa Chemistry not only offer thousands of highly valued D, 13C, 15N, 18O, 34S labeled compounds, but also provide a series of stable isotope related technical services, including CSIA, SILAC, SIP, and SIA, for researchers both at home and abroad.
May 4, 2023
-
BOC Sciences Unveils Comprehensive Capabilities of Custom Peptide Drug Conjugate
BOC Sciences unveils its comprehensive capabilities of custom peptide drug conjugate from project design to commercial production.
May 7, 2023
-
Functional Diamonds: Unlocking Possibilities in Various Fields
May 4, 2023
-
Exothera Nucleic Acids Strengthens Team with Industry Expert
Exothera Nucleic Acids has announced the appointment of Dr. Patrick Thiaville as Chief Technology Officer to support its growth in the rapidly expanding RNA therapies market.
May 8, 2023
-
Thermo Fisher Scientific Expands ImmunoCAP™ Test Availability Across U.S.
Thermo Fisher Scientific today announced its expansion of ImmunoCAP™ Specific IgE test availability to more patients across the U.S. through all Kroger Health The Little Clinic locations.
May 10, 2023
-
CureSearch to fund new study for aggressive pediatric bone cancer
Although overall survival rates for childhood osteosarcoma are improving, there have been no significant improvements in survival outcomes for patients with metastasis. CureSearch is funding a novel study that may highly impact the survival of osteosarcoma patients by uncovering new clinical opportunities for treatment.
May 7, 2023
-
PEGS Week 2023: Creative Biolabs Unveils the Agenda
Creative Biolabs is ready for the PEGS Boston Summit, which will exhibit at booth 205 from May 15–19.
May 13, 2023
-
Amerigo Scientific Unveils 1Step RT PCR Kit to Support RNA Studies and Simply Workflow
Amerigo Scientific unveils 1Step RT PCR Kit for the scientific use of gene-expression analysis, transfection analysis, cDNA cloning, multiplex RT-PCR, etc.
May 7, 2023
-
CD Formulation Unveils Its Latest Offering: A Comprehensive Line of Pharmaceutical Formulation Characterization Testing Services
Apr 24, 2023
-
Huateng Pharma Develops CDK4/6 Inhibitors Against Breast Cancer
Apr 25, 2023
-
Biopharma PEG Supplies PEG Products For Lipid Nanoparticles (LNPs)
Apr 25, 2023
-
Paradigm Clinical Research Announces Expansion of Site Locations
Apr 26, 2023
-
Exothera announces a strategic partnership with Quantoom Biosciences and launches a new business unit for the development and production of RNA
Exothera has partnered with Quantoom Biosciences to gain access to Quantoom’s Nfinity technology, a continuous production platform for RNA.
Apr 25, 2023


